| Current Price | $73.31 | Mkt Cap | $3.1B |
|---|---|---|---|
| Open | $71.35 | P/E Ratio | 0.00 |
| Prev. Close | $73.31 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $71.07 - $74.16 | Volume | 931,792 |
| 52-Wk Range | $20.63 - $82.00 | Avg. Daily Vol. | 971,062 |
| Current Price | $73.31 | Mkt Cap | $3.1B |
|---|---|---|---|
| Open | $71.35 | P/E Ratio | 0.00 |
| Prev. Close | $73.31 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $71.07 - $74.16 | Volume | 931,792 |
| 52-Wk Range | $20.63 - $82.00 | Avg. Daily Vol. | 971,062 |
The best Bull and Bear pitches based on recency and number of recommendations.
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth… More
CNS diseases with patient-reported outcomes are so difficult to show efficacy.
Read the most recent pitches from players about AXSM.
Recs
TMFAdriaCimino
(< 20)
Submitted: 9/13/2022 2:40:57 PM :
Start Price:
$60.23
NASDAQ:AXSM Score:
+20.63
Axsome just acquired a drug for sleep disorders -- and that drug saw triple-digit sales growth last year. And Axsome just won FDA approval for a drug for major depressive disorder. This is expected to become a blockbuster. These are two key growth drivers that are at the beginning of their story.
Recs
TMFjimhalley
(< 20)
Submitted: 5/12/2022 1:07:26 PM :
Start Price:
$24.94
NASDAQ:AXSM Score:
+191.33
The company should benefit from revenue from Sunosi, as well as AXS-05, when that drug is approved.
Recs
folge
(< 20)
Submitted: 5/2/2022 3:54:45 PM :
Start Price:
$34.10
NASDAQ:AXSM Score:
+118.29
They're about to commercialize the world's next blockbuster drug - AXS-05 - and have many others with positive testing results.
Find the members with the highest scoring picks in AXSM.
jeepdrew222 (61.04) Score: +2,680.89
The Score Leader is the player with the highest score across all their picks in AXSM.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| jeepdrew222 | 61.04 | 8/27/2018 |
|
5Y | $2.60 | +2,719.62% | +38.72% | +2,680.89 | 0 Comment | |
|
Under5 | 65.28 |
|
|
5Y | $2.60 | +2,719.62% | +53.65% | +2,665.97 | 0 Comment |
| NextGenStock | < 20 | 6/20/2018 |
|
5Y | $3.00 | +2,343.67% | +45.05% | +2,298.62 | 0 Comment | |
| NateVDM214 | < 20 | 6/21/2018 |
|
3Y | $3.15 | +2,227.30% | +45.21% | +2,182.09 | 0 Comment | |
| jumbofaceplate | 21.27 | 5/15/2017 |
|
5Y | $4.10 | +1,688.05% | +67.34% | +1,620.71 | 0 Comment | |
|
|
ababrmon | 60.73 | 1/2/2018 |
|
5Y | $5.47 | +1,240.51% | +49.36% | +1,191.16 | 0 Comment |
| warmwind | < 20 | 1/13/2017 |
|
5Y | $5.50 | +1,232.91% | +76.74% | +1,156.17 | 0 Comment | |
| clangmead | 47.53 | 1/15/2019 |
|
5Y | $7.52 | +874.87% | +55.43% | +819.44 | 0 Comment | |
| Momentum21 | 85.11 | 6/2/2016 |
|
5Y | $7.68 | +854.56% | +90.59% | +763.97 | 0 Comment | |
| Reallynow222 | 91.90 | 2/28/2019 |
|
5Y | $8.20 | +794.02% | +43.51% | +750.52 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
